Earth Science Tech (ETST) Revenue Growth (1y) (2012 - 2026)

Earth Science Tech (ETST) Revenue Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 2.34%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 2.91%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -11.85%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -1.62%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 7.85%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 42.25%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 14.92%
10 Earth Science Tech 32.24 Mn 30.08 Mn 6.27 Mn 9.46%

Historic Data

Download Data
DateValue
Mar 31, 2026 9.46%
Dec 31, 2025 14.06%
Sep 30, 2025 6.24%
Jun 30, 2025 2.23%
Mar 31, 2025 44.24%
Dec 31, 2024 94.00%
Sep 30, 2024 341.92%
Jun 30, 2024 3,796.13%
Mar 31, 2024 12,976.84%
Dec 31, 2023 149,529.37%
Mar 31, 2023 25,316.57%
Dec 31, 2022 -36.63%
Mar 31, 2022 -99.01%
Dec 31, 2021 -83.30%
Sep 30, 2021 -90.75%
Jun 30, 2021 -89.61%
Mar 31, 2021 -70.13%
Dec 31, 2020 -75.44%
Sep 30, 2020 -80.99%
Jun 30, 2020 -68.34%